Tareq Abadl։ Why You Should Never Separate Serum Before Clotting Is Complete
Tareq Abadl, Medical Lab Specialist, shared a post on LinkedIn:
”Why You Should never Separate Serum Before Clotting Is Complete
In many labs, there’s a tendency to rush and centrifuge samples immediately after collection…
But doing this can seriously compromise your results.
What Actually Happens?
When blood is collected in a plain tube (no anticoagulant), it naturally begins the clotting process.
Fibrinogen is converted into fibrin, forming a mesh that traps blood cells and allows clear serum to separate.
This process takes about 20 to 30 minutes to complete.
If you centrifuge before full clot formation:
Clotting continues during centrifugation, leading to serum that is:
Not clear
- Contains fibrin strands or microclots
- Appears turbid or uneven
Impact on Laboratory Results
Enzymes (AST, ALT, CK, LDH):
Premature separation can cause cellular stress or microclot formation, leading to falsely elevated enzyme levels.
Glucose:
Blood cells continue consuming glucose if clotting is not complete, resulting in falsely low values.
Urea and Creatinine:
Ongoing interaction between cells and partially separated serum may alter concentrations and reduce accuracy.
Proteins and Albumin:
Residual clots can trap proteins, leading to falsely decreased values.
Bottom Line:
Early separation results in an unreliable sample.
Repeat testing leads to wasted time, effort, and cost.
Waiting 20 to 30 minutes ensures clear serum and accurate results.
Practical Lab Tips:
Always allow 20 to 30 minutes for complete clotting
Centrifuge at appropriate settings (about 3000 revolutions per minute for 10 minutes)
Visually inspect serum to ensure it is free of fibrin
Key Message: Good pre-analytical practice leads to trustworthy results.”

Other posts featuring Tareq Abadl on Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support